Page last updated: 2024-10-24

celecoxib and Erdheim-Chester Disease

celecoxib has been researched along with Erdheim-Chester Disease in 1 studies

Erdheim-Chester Disease: A rare form of non-Langerhans-cell histiocytosis (HISTIOCYTOSIS, NON-LANGERHANS-CELL) with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogáts, G1
Piros, G1
Tiszlavicz, L1
Iványi, B1
Sasi, V1
Csepregil, L1
Simon, J1
Babik, B1
Csillik, A1
Kardos, L1
Palkó, A1
Matin, K1
Hanzély, Z1
Korányi, K1
Nyáry, I1
Végh, M1
Kolozsvári, L1
Kahán, Z1
Bajcsay, A1
Tóth, A1
Balázs, G1
Simor, T1
Pávics, L1
Palotás, A1

Other Studies

1 other study available for celecoxib and Erdheim-Chester Disease

ArticleYear
Erdheim-Chester's disease of the heart: a diagnostic conundrum and collision with the same mass in the orbit.
    The heart surgery forum, 2006, Volume: 9, Issue:1

    Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Erdheim-Chester Disease; Heart Diseases; Humans; Male; Middl

2006